在切除的乙型肝炎病毒相关的肝细胞癌中不同的核类型:系统性审查
Hongquan Qiu1, Yu Zhang2, Fengxia Xu3
1Department of Nursing, Nantong Health College of Jiangsu Province, Nantong, Jiangsu, China.
Frontiers in pharmacology
|December 1, 2025
概括
泰尔比武丁和诺福维尔二松 fumarate显著提高了B型肝炎病毒相关肝细胞癌 (HBV-HCC) 患者的生存率. 这些核胺类比为整体和无复发的生存提供了优越的好处.
科学领域:
- 肝病学和瘤学 肝病学和瘤学
- 病毒性肝炎研究研究
- 癌症治疗策略 癌症治疗策略
背景情况:
- 肝细胞癌 (HCC) 经常发生于慢性乙型肝炎病毒 (HBV) 感染的次要原因.
- 激光切除是HBV相关的HCC (HBV-HCC) 的首要治疗方法.
- 核类同类在改善HBV-HCC患者切除后生存结果中的作用需要全面评估.
研究的目的:
- 进行一个网络元分析,评估各种核类同类的比较疗效.
- 评估这些抗病毒疗法对HBV-HCC患者在彻底切除后的整体存活率 (OS) 和无复发存活率 (RFS) 的影响.
主要方法:
- 在PubMed,Embase,Cochrane Library和CNKI数据库中进行了系统的文献搜索.
- 用于队列研究的纽卡斯尔-太华尺度 (NOS) 和用于RCT的ROB工具来评估偏差风险.
- 对OS和RFS的危险比率 (HRs) 和95%可信区间 (CrIs) 使用R软件进行元分析.
主要成果:
- 分析了24项涉及9787名HBV-HCC患者的研究.
- 与对照组相比,telbivudine和tenofovir disoproxil fumarate在OS和RFS中表现出最显著的改善.
- 泰尔比武丁在OS (98.22% SUCRA) 和RFS (93.22% SUCRA) 中显示出最高的疗效,紧随其后的是特诺福维尔二松醇烟酸.
结论:
- 泰尔比乌丁和诺福维尔二氧化硫 fumarate 是优越的核类相应物,用于增强HBV-HCC患者在基切除后的生存结果.
- 这些发现支持使用特定的核类型作为辅助疗法,以改善HBV-HCC患者的长期预后.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mechanisms of Retrovirus-induced Cancers
6.8K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.8K
Subviral Agents
475
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
475
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Viruses with RNA Genomes
751
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
751
Retrovirus Life Cycles
49.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
49.2K


